<DOC>
	<DOCNO>NCT02385630</DOCNO>
	<brief_summary>Surgery cornerstone treatment patient oesophageal gastric cancer , surgical removal tumour ( oesophagectomy gastrectomy ) may offer best chance cure , major operation associate specific long term complication . Weight loss poor nutrition relatively common problem among patient attain long-term cancer remission cure surgery . The mechanisms underlying problem well understood therefore treatment option limit . The investigator research demonstrate increased level chemical messenger ( gut hormone ) release gastrointestinal tract meal patient previously undergone upper gastrointestinal surgery . These chemical messenger play role signal feel fullness meal ( satiety ) . Understanding mechanism involve increased gut hormone secretion operation may allow u use certain medication block gut hormone release hence reduce satiety allow patient eat , regain weight prevent nutritional complication surgery . Exaggerated post-prandial satiety gut hormone responses follow oesophagectomy , however , establish cross-sectionally therefore time course development increase gut hormone secretion unknown . Data collect study provide important information optimal timing therapeutic intervention patient group , offer mechanistic insight regard pathophysiologic process underlie post-operative early satiety .</brief_summary>
	<brief_title>Longitudinal Assessment Gut Hormone Secretion Following Upper Gastrointestinal Surgery Cancer</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Patients schedule undergo twostage , threestage transhiatal oesophagectomy gastric conduit reconstruction OR total gastrectomy RouxenY reconstruction 1 . Significant persistent chemoradiotherapy complication 2 . Other previous upper gastrointestinal surgery 3 . Unwell unable eat 4 . Other disease medication may affect satiety gut hormone responses 5 . Active significant psychiatric illness include substance misuse 6 . Cognitive communication issue factor affect capacity consent participation 7 . History significant food allergy , certain dietary restriction 8 . Confirmed suspected residual recurrent disease surgery , synchronous metachronous malignancy 9 . Significant surgical complication , aspiration risk deterioration performance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Longitudinal Studies</keyword>
	<keyword>Esophagectomy</keyword>
	<keyword>Gastrectomy</keyword>
	<keyword>Hunger</keyword>
	<keyword>Appetite</keyword>
	<keyword>Glucagon-like Peptide 1</keyword>
	<keyword>Peptide YY</keyword>
	<keyword>Ghrelin</keyword>
	<keyword>Satiety Response</keyword>
	<keyword>Feeding Behavior</keyword>
	<keyword>Meals</keyword>
	<keyword>Postprandial Period</keyword>
</DOC>